Join our expert faculty in a Live Virtual Symposium as they discuss therapeutic approaches for patients with HER2-positive early breast cancer. The latest evidence and rationale for neoadjuvant and adjuvant treatment strategies will be discussed, as well as optimal application in routine practice. What do surgeons need to know? Please come with your most pressing questions. 

This program is developed in Partnership with Medscape Education Global.

To register https://www.medscape.org/sites/townhall/public/her2-pos-ebc